Skip to main content

CORRECTION article

Front. Neurol., 15 March 2023
Sec. Neuromuscular Disorders and Peripheral Neuropathies
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1179017

Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

This article is a correction to:

  1. Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

    1. Read original article
\nXin Huang,&#x;Xin Huang1,2†Hao Ran&#x;Hao Ran3†Yingkai Li,Yingkai Li1,2Qian Ma,Qian Ma1,2Changyi Ou,Changyi Ou1,2Li Qiu,Li Qiu1,2Huiyu Feng, Huiyu Feng1,2*Weibin Liu, Weibin Liu1,2*
  • 1Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 2Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China
  • 3School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China

A corrigendum on
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients

by Huang, X., Ran, H., Li, Y., Ma, Q., Ou, C., Qiu, L., Feng, H., and Liu, W. (2022). Front Neurol. 13:961628. doi: 10.3389/fneur.2022.961628

In the published article, an author name was incorrectly written as Yingkia Li. The correct spelling is Yingkai Li.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: myasthenia gravis, leflunomide, low dose prednisone, Th1 cells, Th2 cells, Th17 cells, Th9 cells

Citation: Huang X, Ran H, Li Y, Ma Q, Ou C, Qiu L, Feng H and Liu W (2023) Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients. Front. Neurol. 14:1179017. doi: 10.3389/fneur.2023.1179017

Received: 03 March 2023; Accepted: 06 March 2023;
Published: 15 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Huang, Ran, Li, Ma, Ou, Qiu, Feng and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Huiyu Feng, fenghuiy@mail.sysu.edu.cn; Weibin Liu, liuwb@mail.sysu.edu.cn

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.